Gainers
- Proteostasis Therapeutics Inc PTI shares climbed 54.11 percent to close at $6.38 on Tuesday after the biopharmaceutical company that focuses on treating diseases caused by an imbalance in the proteostasis network announced an update. The company said the FDA granted a Breakthrough Therapy Designation for its PTI-428, a cystic fibrosis transmembrane conductance regulator (CFTR) amplifier.
- Endocyte, Inc. ECYT gained 22.54 percent to close at $10.82.
- BlueLinx Holdings Inc. BXC shares rose 21.51 percent to close at $34.06. BlueLinx shares gained 77.52 percent Monday after the company reported a $413 million merger with Cedar Creek.
- Bovie Medical Corporation BVX gained 21.12 percent to close at $2.81 following a fourth quarter earnings and sales beat.
- Orgenesis Inc. ORGS rose 20.82 percent to close at $11.1758.
- Athersys, Inc. ATHX gained 17.95 percent to close at $1.84 after biotechnology company that focuses on regenerative medicine received an equity investment. The company said it received a $21 million equity investment at $1.76 per share from Healios K.K. as part of a plan to significantly expanding their existing development and commercialization collaboration.
- Atomera Incorporated ATOM shares jumped 17.17 percent to close at $7.03 on Tuesday.
- Allena Pharmaceuticals, Inc. ALNA gained 14.46 percent to close at $7.60.
- American Vanguard Corp. AVD rose 14.32 percent to close at $23.15 as the company posted upbeat quarterly results.
- Myovant Sciences Ltd. MYOV shares climbed 13.65 percent to close at $19.23.
- Vaxart, Inc. VXRT rose 13.58 percent to close at $6.94 on Tuesday.
- Northstar Realty Europe Corp NRE gained 12.09 percent to close at $12.42 following Q4 results.
- Xplore Technologies Corp. XPLR rose 11.45 percent to close at $3.70 on Tuesday.
- DSW Inc. DSW shares gained 10.71 percent to close at $21.70. DSW reported stronger-than-expected earnings for its fourth quarter, while sales missed estimates.
- Purple Innovation, Inc. PRPL climbed 10.56 percent to close at $12.15.
- BRT Apartments Corp. BRT shares gained 9.92 percent to close at $11.41 on Tuesday. BRT Apartments raised its quarterly dividend by around 11.1 percent.
- Sify Technologies Limited SIFY shares climbed 9.5 percent to close at $2.19.
- Zosano Pharma Corp ZSAN gained 8.5 percent to close at $16.70. Zosana Pharma reported a Q4 loss of $3.80 per share on Monday.
- MediciNova, Inc. MNOV rose 6.02 percent to close at $13.91.
- Cutera, Inc. CUTR rose 5.34 percent to close at $53.30. Stephens & Co. initiated coverage on Cutera with an Overweight rating.
- M.D.C. Holdings, Inc. MDC gained 4.98 percent to close at $29.70. UBS upgraded M.D.C. from Sell to Buy.
- HD Supply Holdings Inc HDS rose 3.31 percent to close at $38.09 as the company reported better-than-expected earnings for its fourth quarter an issued a strong forecast for FY18.
Check out these big penny stock gainers and losers
Losers
- Silicom Ltd. SILC shares tumbled 30.57 percent to close at $40.66 on Tuesday.
- CGG SA (ADR) CGG shares declined 24.56 percent to close at $2.15 on Tuesday after dropping 31.33 percent on Monday.
- iFresh Inc. IFMK dropped 24.41 percent to close at $6.69.
- CounterPath, Corp. CPAH fell 22.89 percent to close at $3.57 after the company reported results for its third quarter.
- Commercial Vehicle Group, Inc. CVGI shares tumbled 19.96 percent to close at $8.90 after the company posted downbeat results for its fourth quarter.
- Marathon Patent Group Inc MARA declined 18.93 percent to close at $1.97.
- Tilly's Inc TLYS fell 17.5 percent to close at $11.83 after the company reported weaker-than-expected results for its fourth quarter. The company also issued weak first quarter guidance.
- Fanhua Inc (ADR) FANH fell 16.04 percent to close at $27.21. Fanhua reported Q4 earnings of $0.30 per share on sales of $106.12 million.
- RXi Pharmaceuticals Corporation RXII shares tumbled 14.89 percent to close at $3.20.
- Aralez Pharmaceuticals Inc ARLZ shares dipped 13.86 percent to close at $1.74. Aralez reported a Q4 loss of $0.68 per share on sales of $28 million.
- Phoenix New Media Ltd ADR FENG fell 12.24 percent to close at $5.02 following Q4 results.
- Myriad Genetics, Inc. MYGN fell 12.14 percent to close at $29.01.
- Advaxis, Inc. ADXS fell 11.76 percent to close at $1.95. Advaxis reported a Q1 loss of $0.49 per share and announced a clinical hold in axalimogene filolisbac Phase 1/2 combination study with AstraZeneca's IMFINZI.
- Pacific Ethanol, Inc. PEIX shares dropped 11.44 percent to close at $3.675.
- Daxor Corporation DXR shares fell 11.35 percent to close at $5.00 on Tuesday.
- China Customer Relations Centers, Inc. CCRC shares dipped 11.21 percent to close at $13.55.
- Madrigal Pharmaceuticals Inc MDGL fell 10.89 percent to close at $127.345. Madrigal Pharma reported a Q4 loss of $0.67 per share.
- Net Element, Inc. NETE shares dropped 10.52 percent to close at $12.08.
- Atara Biotherapeutics, Inc. ATRA shares fell 10.42 percent to close at $41.25 on Tuesday.
- Innovate Biopharmaceuticals Inc INNT declined 9.69 percent to close at $17.00. Innovate Biopharmaceuticals named Dr. June Almenoff as COO and Chief Medical Officer.
- Vocera Communications Inc VCRA shares fell 9.09 percent to close at $24.79. Leerink Swann downgraded Vocera Communications from Outperform to Market Perform.
- Helios and Matheson Analytics Inc HMNY shares fell 9.07 percent to close at $4.01.
- QUALCOMM, Inc. QCOM shares fell 4.95 percent to close at $59.70 in reaction to U.S. President Donald Trump's move to block Broadcom Ltd AVGO's proposed takeover of the U.S.-based digital communication technology company. Trump cited "credible evidence" the takeover led by the Singapore-based company "threatens to impair the national security of the US."
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasLowersMovers From YesterdayTop GainersYesterday's Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in